Skip to main content
. 2022 Nov 22;10:942325. doi: 10.3389/fbioe.2022.942325

TABLE 2.

Physical delivery of CRISPR/Cas systems.

Approaches Delivery strategies CRISPR/Cas systems Target genes Target cells/tissues Species/diseases References
Microinjection in vitro Cas9 mRNA and sgRNAs Ppar-γ, Rag1 One-cell embryos Cynomolgus monkey Niu et al. (2014)
in vitro Cas9 mRNA and sgRNAs APOE, B2M, PRF1, and PRKDC Fertilized eggs Rat Ma et al. (2014)
in vitro Cas9 mRNA and sgRNAs Gal4 Embryos Zebrafish Kimura et al. (2014)
in vitro Cas9 mRNA and sgRNAs APOE, CD36, CFTR, LDLR, apoC-III, SCARB1, LEP, LEP-R, RyR2 Embryos Rabbits Yang et al. (2014)
in vitro Cas9 mRNA and sgRNAs MSTN Zygotes Sheep Crispo et al. (2015)
in vitro Cas9 protein and sgRNA - Embryos Xenopus laevis Corkins et al. (2022)
Electroporation in vitro CRISPR/Cas9 plasmid APPSwe, PSEN1M146V iPS cells Human Paquet et al. (2016)
in vitro CRISPR/Cas9 plasmid exon 45–55 mutation hotspot region Myoblasts DMD Ousterout et al. (2015)
ex vivo CRISPR/Cas9 plasmid PD-1 Human primary T cells Cancer Su et al. (2016)
ex vivo Cas9/sgRNA RNP TGFBR2, HPRT1 Human NK Cells - Naeimi et al. (2018)
In vivo Cas9/sgRNA RNP Sox2, GFP - Axolotl Fei et al. (2016)
in vivo Cas9/sgRNA RNP exon80 Skin Mouse Wu et al. (2017b)
Hydrodynamic injection in vivo CRISPR/Cas9 plasmid HBV Hepatoma cells Transgenic mouse Zhu et al. (2016)
in vivo CRISPR/Cas9 plasmid Pten, p53 Liver Mouse Xue et al. (2014)
Membrane deformation in vitro CRISPR/Cas9 plasmid GFP, NUAK2, AAVS1 293T, MCF7, SUM159, SU-DHL-1, AB2.2 Human, mouse Han et al. (2015)
Sonoporation in vitro Cas9/sgRNA RNP GFP B16F10 Mouse Hansen-Bruhn et al. (2018)
Lance array nanoinjection in vitro CRISPR/Cas9 plasmid GFP HeLa Human Sessions et al. (2016)

Notes: Ppar-γ: peroxisome proliferator-activated receptor; Rag1: recombination activating 1; APOE: apolipoprotein; B2M: beta-2-microglobulin; PRF1: perforin 1; PRKDC: protein kinase, DNA-activated, catalytic subunit; GAL4: galactose-responsive transcription factor; CD36: cluster of differentiation 36; CFTR: cystic fibrosis transmembrane conductance regulator; LDLR: low-density lipoprotein receptor; apoC-III: apolipoprotein C-III; SCARB1: scavenger receptor class B,member1; LEP: leptin; LEP-R: leptin receptor; RyR2: ryanodine receptor 2; MSTN: myostatin; iPS: pluripotent stem cells; APPSwe: amyloid precursor protein; PSEN1M146V: presenilin 1; DMD: duchenne muscular dystrophy; PD-1: programmed death-1; TGFBR2: TGF-beta type II, receptor; HPRT1: hypoxanthine phosphoribosyltransferase 1; HBV: hepatitis B virus; GFP: green fluorescent protein; RNP: ribonucleoprotein.